INSIGHTS Podcast Series — #20: Barath and Radhika on the Healthcare Landscape in India

We continue with the #INSIGHTSPodcast Series and in this episode, we focus on the healthcare sector and discuss opportunities and the market landscape using examples from the Accel portfolio. To talk about this exciting topic, We have Barath & Radhika, Principal & Sr Associate at Accel whose core focus investment areas are in Life sciences, Medtech and digital health.

On this podcast, we discuss the healthcare landscape in India using examples from the Accel portfolio and what to look for while building out a healthcare company from India :

Examples from Accel portfolio on problems being solved in healthcare for global markets

  • Lifesciences
    What is life sciences — the model of an IP led lifesciences company solving global problems
  • Mitra Biotech
    Why did they choose to start in India?
    The solution to an age old problem — How do you understand the effects of drugs on tumors without bombarding a patient with the drugs
  • Zumutor
    Building a platform to develop molecules for improving drug delivery to cancer cells
  • Healthcare Delivery
    The problems with the healthcare delivery in India
    Moving care back to the home — counter intuitive insight and how Portea plugs the gaps in the delivery space
  • Digital health
    Onco.com — using digital distribution to disrupt the current value chain and deliver better care for patients
  • Using AI to deliver healthcare in the diagnostics space — How sigtuple uses digital distribution and AI to deliver healthcare and diagnose correctly.

The Indian Advantage — Why healthcare is attractive in India

  • Capital efficiency from being in India
    3x-5x advantage in capital required from building from India
    Talent, Infrastructure arbitrage from India — The Indian pharma story for next wave of lifesciences
  • Speeding things up — How India helps speed up development
    The regulatory advantage — lesser regulations for initial development of drugs. Using the initial momentum and taking the drugs to more regulated markets for trials — the difficulty of trials in the Indian market
  • Examples where the thesis on cost and time plays out
    The estimates from Axio — getting to market with 1/10th the capital and 60% of the time to get to market with a great product
    Setting the standards in India so the product goes global — no compromise on quality

The healthcare business — things to consider while getting into the healthcare sector

  • The trust process — building trust, and the time and effort it takes to build trust
  • Importance of IP — having a good IP and using peer-reviewed publications for validation and marketing
  • Patent portfolio and defensiblity of patents — defending incremental IP and not infringing existing patents, and filing patents to get it out in the world
  • The team — building a team as the company grows, and the expertise required; the differences between life sciences, and non-life science businesses
  • The Indian story — shift from communicable to chronic disease, infrastructure gap, mobile first country and the advantage technology provides in such an environment.

Accel shares such interesting entrepreneurial stories, with informative nuggets to run and scale your startup. Follow the links below and subscribe to our #Accel #INSIGHTSPodcast Series using the following links: iTunes, Twitter@Accel_India, Google Music: (US & Canada Only)and the RSS feed

Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

Create a free website or blog at WordPress.com.

Up ↑

%d bloggers like this: